|
Events related to PRES
|
| Headache, visual impairment, disturbance of consciousness, mental status changes, movement disorders and seizures |
A1, A6, A7, A13, A15, A23, A34, A36, A39, A40, A48, A50, A51, A52, A49, A64, A66, A67, A70 |
19(26.76) |
| Confusion, difficulty finding words, disorientation, aphasia, drowsiness, seizures, or brain swelling |
A11, A16, A24, A26, A44 |
5(7.04) |
| Difficulty finding words, aphasia, confusion, cognitive impairment, depressed level of consciousness, attention disorders, mental status changes, drowsiness, automatisms, lethargy, dysphasia, dysarthria, tremor, delirium, and/or hallucinations |
A8, A25, A29, A68 |
4(5.63) |
| Brain disorder affecting white matter, vasogenic changes, reversible focal edematous, headache, nausea and vomiting, seizures, visual disturbances, sensory changes, and occasionally focal neurologic deficit |
A31 |
1(1.40) |
| Cytotoxic edema without enhancement and confusion |
A33 |
1(1.40) |
| Delirium, somnolence, obtundation, cognitive disturbance, dysphasia, tremor, ataxia, myoclonus, focal motor and sensory defect seizures, cerebral edema |
A38 |
1(1.40) |
| Headache, tremor, mild aphasia, mild motor disturbances, intracranial hemorrhage, and fatal rapid-onset diffuse cerebral edema |
A42 |
1(1.40) |
|
Events related to posterior reversible leukoencephalopathy
|
| Posterior reversible leukoencephalopathy, seizures, ototoxicity, pancerebellar syndrome, necrotizing microangiopathy, transient stroke-like episodes, encephalitis, immune reconstitution inflammatory syndrome, Guillain-Barré syndrome, reversible cerebellar disease, peripheral sensorimotor neuropathy, optic neuropathy and autonomic dysfunction, visual hallucinations, progressive multifocal leukoencephalopathy, mutism, pseudotumor cerebri, brachial plexopathy, hearing loss, cortical blindness, hypertensive encephalopathy, headache, hypomagnesemia, white matter lesions |
A4, A45, A54, A57, A69 |
5(7.04) |
| Visual disturbances, progressive, peripheral neuropathy, dementia, ataxia, hemiparesis, quadriparesis, and blindness, sometimes leading to coma and death, seizures, varying extents of necrosis, areas of enlarged astrocytes and oligodendrocytes, and multiple lesions |
A46 |
1(1.40) |
| Intracranial hemorrhages, focal seizures, posterior reversible leukoencephalopathy syndrome, focal neurologic deficit, seizures, and strabismus |
A35 |
1(1.40) |
| Seizures, cerebellar ataxia, cerebral atrophy, intracranial hemorrhage, and oculomotor nerve palsy |
A17 |
1(1.40) |
|
Other events
|
| Convulsions, mental confusion, infectious encephalitis, headache, writing difficulty, aphasia, brain swelling, delirium, decreased level of consciousness, language disorder, apraxia, lethargy, myoclonus, obtundation |
A9, A10, A12, A22, A37, A41, A58, A62 |
8(11.26) |
| CRS and leukoencephalopathy |
A59, A61, A71 |
3(4.22) |
| Bleeding complications, thrombocytopenia, coagulopathies, cerebral infarction, fungal neuropathology, Wernicke’s encephalopathy, altered mental status, ataxia and ophthalmoplegia |
A2, A55 |
2(2.81) |
| Mental confusion, cognitive impairment, headache, tremor, Guillain-Barré syndrome, aphasia and seizures |
A19, A20 |
2(2.81) |
| Seizures, loss of vision in the absence of local pathology, altered level of consciousness (ALOC), involuntary movements, ataxia, paresis, cranial nerve palsy, speech impairment, and delirium |
A5 |
1(1.40) |
| Reversible neurotoxicity, headache, emesis, and transient limb muscle clonus |
A14 |
1(1.40) |
| Moderate cerebellar syndrome, central neuropathy, peripheral neuropathy, hemiparesis and facial palsy |
A18 |
1(1.40) |
| Mental confusion, fatigue, seizures, tremors, hyperesthesia/paresthesia, spinal demyelination, coma, cortical blindness, transient speech loss, and cerebellar syndrome |
A21 |
1(1.40) |
| Severe neurotoxicity, seizures, leukoencephalopathy, hallucinations and cortical blindness |
A53 |
1(1.40) |
| Demyelination |
A28 |
1(1.40) |
| Mental confusion, disorientation, impaired responsiveness, visual hallucinations, delusions, motor and/or generalized seizures, changes in mental status and/or level of consciousness, peripheral nervous system changes, pyramidal motor weakness, tremor, cortical blindness, aphasia, and ataxia |
A56, A60, A63, A65 |
4(5.63) |
|
Other encephalopathy
|
| Wernicke’s encephalopathy (mental, eye, and balance disorders) |
A43 |
1(1.40) |
| Metabolic encephalopathy, intracranial hemorrhage, epileptic seizures, CNS infections, brain abscesses, cerebral infarction, posterior reversible leukoencephalopathy syndrome, movement disorder, Wernicke’s encephalopathy and neuroleptic syndrome |
A32 |
1(1.40) |
| Reversible encephalopathy syndrome, intracranial hemorrhage, cerebral venous sinus thrombosis, CNS infection, leukoencephalopathy, bruising and brain parenchyma |
A30 |
1(1.40) |
| Limbic encephalopathy, cerebrovascular complications (subdural hematoma, subarachnoid hemorrhage), encephalopathy, invasive aspergillosis, hemophagocytic syndrome, and leukoencephalopathy |
A27 |
1(1.40) |
| Metabolic encephalopathy, intracranial hemorrhage, ischemic stroke, PRES, seizures, and neuropathy |
A47 |
1(1.40) |
| Metabolic encephalopathy, posterior reversible leukoencephalopathy, visual disturbances, cortical blindness, CNS infection, cerebral toxoplasmosis infection, bacterial meningitis, intracerebral abscesses, meningoencephalitis, multiple hemorrhages, cerebral, transient ischemic attacks, headache, visual disturbances, and tremor |
A3 |
1(1.40) |
Thumbnail
